NASDAQ:FBLG | Cash Flow Statement | FibroBiologics, Inc.

Complete source-backed cash-flow history.

Available history
2022-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$4.12M
2026-03-31-$5M-$4.36M$0.00$0.00$952,000.00
2025-12-31-$3.24M-$3.16M$0.00$0.00$3.19M
2025-09-30-$5.78M
2025-06-30-$4.66M
2025-03-31-$4.97M-$5.28M$43,000.00-$43,000.00$0.00
2024-12-31-$3.1M-$3.07M$99,000.00-$99,000.00$9.33M
2024-09-30-$500,000.00
2024-06-30$898,000.00
2024-03-31-$8.46M-$4.28M$8,000.00-$8,000.00$3.28M
2023-12-31-$9.72M-$1.6M$2,000.00-$2,000.00$0.00
2023-09-30-$2.19M
2023-06-30-$2.16M
2023-03-31-$2.42M-$2.04M$56,000.00-$56,000.00$14.57M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$18.65M-$16.39M$262,000.00-$262,000.00$7.57M
2024-12-31-$11.16M-$11.9M$184,000.00-$184,000.00$16.91M
2023-12-31-$16.49M-$6.4M$495,000.00-$495,000.00$13.79M
2022-12-31-$5.12M-$4.07M$5.93M